Company intelligence / Profile preview

Ritract

Perth, Western Australia, Australia

Ownership: Private
Development stage: Other

Overview

Ritract Limited was an Australian medical device company primarily focused on the development and commercialization of safety syringe technology. The company's flagship product was a unique, one-handed, auto-retractable safety syringe designed to prevent accidental needle-stick injuries and the reuse of syringes. Despite achieving regulatory approvals and establishing manufacturing partnerships, the company faced significant financial and operational challenges. Ritract was previously listed on the Australian Securities Exchange (ASX) but was eventually delisted and ceased active operations.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Ritract.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ritract.

Explore the full profile